These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4736336)

  • 1. The action of thrombin on blood clotting factor V: conversion of factor V to a prothrombin-binding protein.
    Esmon CT; Owen WG; Duiguid DL; Jackson CM
    Biochim Biophys Acta; 1973 May; 310(1):289-94. PubMed ID: 4736336
    [No Abstract]   [Full Text] [Related]  

  • 2. The conversion of prothrombin to thrombin. IV. The function of the fragment 2 region during activation in the presence of factor V.
    Esmon CT; Jackson CM
    J Biol Chem; 1974 Dec; 249(24):7791-7. PubMed ID: 4473451
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of prothrombin activation by bothrojaracin, a C-type lectin from Bothrops jararaca venom.
    Monteiro RQ; Zingali RB
    Arch Biochem Biophys; 2000 Oct; 382(1):123-8. PubMed ID: 11051105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of blood clotting factor V in the conversion of prothrombin and a decarboxy prothrombin into thrombin.
    Vermeer C; Govers-Riemslag JW; Soute BA; Lindhout MJ; Kop J; Hemker HC
    Biochim Biophys Acta; 1978 Feb; 538(3):521-33. PubMed ID: 564211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on blood coagulation factor V. V. Changes of molecular weight accompanying activation of factor V by thrombin and the procoagulant protein of Russell's viper venom.
    Kahn MJ; Hemker HC
    Thromb Diath Haemorrh; 1972 Feb; 27(1):25-32. PubMed ID: 5033669
    [No Abstract]   [Full Text] [Related]  

  • 6. The conversion of prothrombin to thrombin. I. Characterization of the reaction products formed during the activation of bovine prothrombin.
    Owen WG; Esmon CT; Jackson CM
    J Biol Chem; 1974 Jan; 249(2):594-605. PubMed ID: 4809530
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies of the conversion mechanism of prothrombin into thrombin.
    Okabe H
    Tohoku J Exp Med; 1974 Nov; 114(3):215-25. PubMed ID: 4456684
    [No Abstract]   [Full Text] [Related]  

  • 8. The human prothrombin-activating enzyme.
    Deggeller K; Vreeken J
    Thromb Diath Haemorrh; 1969 Aug; 22(1):45-67. PubMed ID: 5821247
    [No Abstract]   [Full Text] [Related]  

  • 9. Meizothrombin: active intermediate formed during prothrombinase-catalyzed activation of prothrombin.
    Doyle MF; Haley PE
    Methods Enzymol; 1993; 222():299-312. PubMed ID: 8412800
    [No Abstract]   [Full Text] [Related]  

  • 10. The kinetics and cofactor dependence of the two cleavages involved in prothrombin activation.
    Nesheim ME; Mann KG
    J Biol Chem; 1983 May; 258(9):5386-91. PubMed ID: 6687890
    [No Abstract]   [Full Text] [Related]  

  • 11. The action of Russell's viper venom on factor V and the prothrombin-converting principle.
    Prentice CR; Ratnoff OD
    Br J Haematol; 1969 Mar; 16(3):291-302. PubMed ID: 5815894
    [No Abstract]   [Full Text] [Related]  

  • 12. Basic aspects of blood clotting: thrombokinase and cofactors in the conversion of prothrombin to thrombin.
    Ferguson JH; Ennis EG; Latridis PG; White NB
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):647-63. PubMed ID: 5590251
    [No Abstract]   [Full Text] [Related]  

  • 13. The preparation of activated factor X and its action on prothrombin.
    Jesty J; Esnouf MP
    Biochem J; 1973 Apr; 131(4):791-9. PubMed ID: 4737325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The functional significance of vitamin K action. Difference in phospholipid binding between normal and abnormal prothrombin.
    Esmon CT; Suttie JW; Jackson CM
    J Biol Chem; 1975 Jun; 250(11):4095-9. PubMed ID: 1126944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor V.
    Colman RW
    Prog Hemost Thromb; 1976; 3():109-43. PubMed ID: 133374
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationship between factor V and activated factor X in the generation of prothrombinase.
    Barton PG; Jackson CM; Hanahan DJ
    Nature; 1967 May; 214(5091):923-4. PubMed ID: 6054988
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanisms of interaction between a phosphoinositide anticoagulant and a phospholipid activator in the Stypven type conversion of prothrombin to thrombin.
    Kahn MJ; Bourgain RH
    Thromb Diath Haemorrh; 1967 Feb; 17(1-2):273-6. PubMed ID: 4296603
    [No Abstract]   [Full Text] [Related]  

  • 18. A polypeptide region of bovine prothrombin specific for binding to phospholipids.
    Gitel SN; Owen WG; Esmon CT; Jackson CM
    Proc Natl Acad Sci U S A; 1973 May; 70(5):1344-8. PubMed ID: 4514304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of clotting factor V heavy chain with prothrombin and prethrombin 1 and role of activated protein C in regulating this interaction: analysis by analytical ultracentrifugation.
    Luckow EA; Lyons DA; Ridgeway TM; Esmon CT; Laue TM
    Biochemistry; 1989 Mar; 28(5):2348-54. PubMed ID: 2719956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Observations on the Factor V activator present in Russell's viper venom and its action on Factor V.
    Hanahan DJ; Rolfs MR; Day WC
    Biochim Biophys Acta; 1972 Nov; 286(1):205-11. PubMed ID: 4676549
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.